Your browser doesn't support javascript.
loading
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study.
Mitani, Kinuko; Lee, Jong Wook; Jang, Jun Ho; Tomiyama, Yoshiaki; Miyazaki, Koji; Nagafuji, Koji; Usuki, Kensuke; Uoshima, Nobuhiko; Fujisaki, Tomoaki; Kosugi, Hiroshi; Matsumura, Itaru; Sasaki, Ko; Kizaki, Masahiro; Sawa, Masashi; Hidaka, Michihiro; Kobayashi, Naoki; Ichikawa, Satoshi; Yonemura, Yuji; Murotani, Kenta; Shimizu, Mami; Matsuda, Akira; Ozawa, Keiya; Nakao, Shinji.
Afiliación
  • Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Lee JW; Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jang JH; Department of Hematology, Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea.
  • Tomiyama Y; Department of Blood Transfusion, Osaka University Hospital, Osaka, Japan.
  • Miyazaki K; Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, Japan.
  • Nagafuji K; Department of Hematology, Kurume University Hospital, Kurume, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
  • Fujisaki T; Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Kosugi H; Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Matsumura I; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Sasaki K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Kizaki M; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Hidaka M; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Kobayashi N; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Ichikawa S; Department of Hematology, Tohoku University Hospital, Sendai, Japan.
  • Yonemura Y; Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital, Kumamoto, Japan.
  • Murotani K; Biostatistics Center, Kurume University, Kurume, Japan.
  • Shimizu M; Department of Medical Affairs, Kyowa Kirin Co, Ltd, Tokyo, Japan.
  • Matsuda A; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama Medical University, Saitama, Japan.
  • Ozawa K; Division of Hematology, Jichi Medical University, Tochigi, Japan.
  • Nakao S; Division of Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Blood Adv ; 8(6): 1415-1419, 2024 Mar 26.
Article en En | MEDLINE | ID: mdl-38134300
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Receptores Fc / Anemia Aplásica Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Receptores Fc / Anemia Aplásica Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article País de afiliación: Japón